CN103724348B - 一种可可碱的制备方法 - Google Patents
一种可可碱的制备方法 Download PDFInfo
- Publication number
- CN103724348B CN103724348B CN201310688897.7A CN201310688897A CN103724348B CN 103724348 B CN103724348 B CN 103724348B CN 201310688897 A CN201310688897 A CN 201310688897A CN 103724348 B CN103724348 B CN 103724348B
- Authority
- CN
- China
- Prior art keywords
- complete
- theobromine
- reaction
- add
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 title claims abstract description 75
- 229960004559 theobromine Drugs 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims abstract description 44
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229960001948 caffeine Drugs 0.000 claims abstract description 22
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims abstract description 22
- ZVCDLGYNFYZZOK-UHFFFAOYSA-M sodium cyanate Chemical compound [Na]OC#N ZVCDLGYNFYZZOK-UHFFFAOYSA-M 0.000 claims abstract description 21
- NHAXKHSVJBVINX-UHFFFAOYSA-N 3,7-dimethylpurine-2,6-dione;sodium Chemical compound [Na].CN1C(=O)NC(=O)C2=C1N=CN2C NHAXKHSVJBVINX-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000002253 acid Substances 0.000 claims abstract description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 120
- 238000006243 chemical reaction Methods 0.000 claims description 107
- 239000000243 solution Substances 0.000 claims description 52
- 238000006386 neutralization reaction Methods 0.000 claims description 37
- 238000007670 refining Methods 0.000 claims description 9
- 239000011259 mixed solution Substances 0.000 claims description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims 4
- 238000000034 method Methods 0.000 abstract description 20
- LZMQYKYIWVJMIS-UHFFFAOYSA-N 2-(7-methyl-2,6-dioxopurin-3-yl)acetic acid Chemical compound N1C(=O)N(CC(=O)O)C=2N=CN(C)C=2C1=O LZMQYKYIWVJMIS-UHFFFAOYSA-N 0.000 abstract description 12
- HCYFGRCYSCXKNQ-UHFFFAOYSA-N 2-(1,3-dimethyl-2,6-dioxo-7-purinyl)acetic acid Chemical compound O=C1N(C)C(=O)N(C)C2=C1N(CC(O)=O)C=N2 HCYFGRCYSCXKNQ-UHFFFAOYSA-N 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 60
- 239000000463 material Substances 0.000 description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 47
- 239000007788 liquid Substances 0.000 description 42
- 239000008213 purified water Substances 0.000 description 31
- 238000010792 warming Methods 0.000 description 31
- 238000009413 insulation Methods 0.000 description 30
- 229960000583 acetic acid Drugs 0.000 description 26
- 239000012362 glacial acetic acid Substances 0.000 description 18
- YCTSCXLOPJCPDH-UHFFFAOYSA-N 2-(3,7-dimethyl-2,6-dioxopurin-1-yl)acetic acid Chemical class CN1C(=O)N(CC(O)=O)C(=O)C2=C1N=CN2C YCTSCXLOPJCPDH-UHFFFAOYSA-N 0.000 description 14
- 238000001914 filtration Methods 0.000 description 13
- 230000008569 process Effects 0.000 description 13
- 238000003756 stirring Methods 0.000 description 12
- 239000002585 base Substances 0.000 description 11
- 238000007363 ring formation reaction Methods 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 239000002826 coolant Substances 0.000 description 6
- 238000004090 dissolution Methods 0.000 description 6
- 238000005304 joining Methods 0.000 description 6
- 230000035484 reaction time Effects 0.000 description 6
- 238000010583 slow cooling Methods 0.000 description 6
- 230000003068 static effect Effects 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- XGEGHDBEHXKFPX-UHFFFAOYSA-N N-methyl urea Chemical compound CNC(N)=O XGEGHDBEHXKFPX-UHFFFAOYSA-N 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- MLIREBYILWEBDM-UHFFFAOYSA-N cyanoacetic acid Chemical compound OC(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 102000009346 Adenosine receptors Human genes 0.000 description 1
- 108050000203 Adenosine receptors Proteins 0.000 description 1
- 0 Cc1c(C(CC(*)=[U])=O)[n](CI)cn1 Chemical compound Cc1c(C(CC(*)=[U])=O)[n](CI)cn1 0.000 description 1
- LKZUYXCUDBKOKW-UHFFFAOYSA-N N-carbamoylacetamide oxalonitrile Chemical compound C(C)(=O)NC(=O)N.N#CC#N LKZUYXCUDBKOKW-UHFFFAOYSA-N 0.000 description 1
- 229940099471 Phosphodiesterase inhibitor Drugs 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- FNYXJOYPHLKLRW-UHFFFAOYSA-N n,3-dimethyl-5-(methylamino)imidazole-4-carboxamide Chemical compound CNC(=O)C1=C(NC)N=CN1C FNYXJOYPHLKLRW-UHFFFAOYSA-N 0.000 description 1
- 238000007034 nitrosation reaction Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000002571 phosphodiesterase inhibitor Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000000050 smooth muscle relaxant Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310688897.7A CN103724348B (zh) | 2013-12-16 | 2013-12-16 | 一种可可碱的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310688897.7A CN103724348B (zh) | 2013-12-16 | 2013-12-16 | 一种可可碱的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103724348A CN103724348A (zh) | 2014-04-16 |
CN103724348B true CN103724348B (zh) | 2016-04-27 |
Family
ID=50448675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310688897.7A Active CN103724348B (zh) | 2013-12-16 | 2013-12-16 | 一种可可碱的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103724348B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107674032A (zh) * | 2017-10-10 | 2018-02-09 | 石药集团新诺威制药股份有限公司 | 一种咖啡因开环生成可可碱中间体的新方法 |
CN114478530B (zh) * | 2022-02-25 | 2023-09-19 | 陕西嘉禾药业有限公司 | 一种从可可豆中提取高含量可可碱的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0319854B1 (de) * | 1987-12-10 | 1994-03-02 | Boehringer Ingelheim Kg | Verfahren zum Methylieren von Xanthinen |
CN101896484A (zh) * | 2007-12-14 | 2010-11-24 | 百利高贸易(上海)有限公司 | 可可碱生产方法 |
CN102329317A (zh) * | 2011-10-29 | 2012-01-25 | 石药集团新诺威制药股份有限公司 | 一种可可碱的合成方法 |
-
2013
- 2013-12-16 CN CN201310688897.7A patent/CN103724348B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0319854B1 (de) * | 1987-12-10 | 1994-03-02 | Boehringer Ingelheim Kg | Verfahren zum Methylieren von Xanthinen |
CN101896484A (zh) * | 2007-12-14 | 2010-11-24 | 百利高贸易(上海)有限公司 | 可可碱生产方法 |
CN102329317A (zh) * | 2011-10-29 | 2012-01-25 | 石药集团新诺威制药股份有限公司 | 一种可可碱的合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103724348A (zh) | 2014-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104672242A (zh) | 一种替格瑞洛的制备方法 | |
CN101891649A (zh) | 一种制备3-氰基苯甲酸甲酯的新生产方法 | |
CN103724348B (zh) | 一种可可碱的制备方法 | |
CN102060860B (zh) | 一种马波沙星的制备方法 | |
CN102229581B (zh) | 非布司他中间体的制备方法 | |
CN108329205A (zh) | 双(2-乙酰氧基苯甲酸)钙脲化合物的制备方法 | |
CN102911176A (zh) | 一种培美曲塞二钠的制备方法 | |
CN102558080A (zh) | 三嗪环的合成方法 | |
CN102134212B (zh) | 奥拉西坦的制备方法 | |
CN110256425A (zh) | 一种棕榈酸帕利哌酮的合成工艺 | |
CN105152947A (zh) | 一种2-氨基-3,5-二溴苯甲醛的制备方法 | |
CN101580460B (zh) | 一种3,4-二羟基苯乙醇的合成方法 | |
CN104496825B (zh) | 2-氟乙胺盐酸盐的制备方法 | |
CN109912531A (zh) | 高纯度非布司他的制备方法 | |
CN103159673B (zh) | 一种制备吉美嘧啶的精制方法 | |
CN102127081A (zh) | 一种腺嘌呤的制备方法 | |
CN104649966A (zh) | 一种有机中间体5-氰基-3甲基吡啶甲酸的合成方法 | |
CN103613597A (zh) | 一种枸橼酸爱地那非的制备工艺 | |
CN102174012B (zh) | 尼莫地平的制备方法 | |
CN107056787B (zh) | 曲匹地尔的合成工艺 | |
CN102329317B (zh) | 一种可可碱的合成方法 | |
CN104418810A (zh) | 一种左西孟旦的合成新路线 | |
CN106496031A (zh) | 一种提高丙二酸二甲酯收率的方法 | |
CN102838512A (zh) | 肌酸硝酸盐的制备方法 | |
CN106496068A (zh) | 丙二酸二甲酯的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for preparing theobromine Effective date of registration: 20191223 Granted publication date: 20160427 Pledgee: China Everbright Bank Limited by Share Ltd Changchun branch Pledgor: Jilin Shulan Synthetic Pharmaceutical Co., Ltd. Registration number: Y2019980001207 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201207 Granted publication date: 20160427 Pledgee: China Everbright Bank Limited by Share Ltd. Changchun branch Pledgor: JILIN SHULAN SYNTHETIC PHARMACEUTICAL Co.,Ltd. Registration number: Y2019980001207 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of theobromine Effective date of registration: 20201215 Granted publication date: 20160427 Pledgee: China Everbright Bank Limited by Share Ltd. Changchun branch Pledgor: JILIN SHULAN SYNTHETIC PHARMACEUTICAL Co.,Ltd. Registration number: Y2020220000089 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20211228 Granted publication date: 20160427 Pledgee: China Everbright Bank Limited by Share Ltd. Changchun branch Pledgor: JILIN SHULAN SYNTHETIC PHARMACEUTICAL Co.,Ltd. Registration number: Y2020220000089 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |